M*Modal signs new agreement with Transcend
With this new agreement, both the parties have made changes to the previous agreement signed in 2006. The new deal has an initial term ending on 31 December
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.